Almangush A, Bello IO, Keski-Santti H, Makinen LK, Kauppila JH, Pukkila M, Hagstrom J, Laranne J, Tommola S, Nieminen O, Soini Y, Kosma VM, Koivunen P, Grenman R, Leivo I, Salo T. Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer. Head Neck. 2014;36(6):811–8.

Article  PubMed  Google Scholar 

Bao X, Xie L. Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death. J Exp Clin Cancer Res. 2022;41(1):222.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baumeister P, Baumuller K, Harreus U, Reiter M, Welz C. Evaluation of margins in head and neck squamous cell carcinoma from the surgeon's perspective. Head Neck. 2018.

Baumeister P, Hollmann A, Kitz J, Afthonidou A, Simon F, Shakhtour J, Mack B, Kranz G, Libl D, Leu M, Schirmer MA, Canis M, Belka C, Zitzelsberger H, Ganswindt U, Hess J, Jakob M, Unger K, Gires O. High expression of EpCAM and Sox2 is a positive prognosticator of clinical outcome for head and neck carcinoma. Sci Rep. 2018;8(1):14582.

Article  PubMed  PubMed Central  Google Scholar 

Bossi P, Bergamini C, Siano M, Cossu RM, Sponghini AP, Favales F, Giannoccaro M, Marchesi E, Cortelazzi B, Perrone F, Pilotti S, Locati LD, Licitra L, Canevari S, De Cecco L. Functional genomics uncover the biology behind the responsiveness of head and neck squamous cell cancer patients to cetuximab. Clin Cancer Res. 2016;22(15):3961–70.

Article  CAS  PubMed  Google Scholar 

Bowser JL, Blackburn MR, Shipley GL, Molina JG, Dunner K Jr, Broaddus RR. Loss of CD73-mediated actin polymerization promotes endometrial tumor progression. J Clin Invest. 2016;126(1):220–38.

Article  PubMed  Google Scholar 

Brabletz S, Schuhwerk H, Brabletz T, Stemmler MP. Dynamic EMT: a multi-tool for tumor progression. EMBO J. 2021;40(18): e108647.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brakenhoff RH, Wagner S, Klussmann JP. Molecular patterns and biology of HPV-associated HNSCC. Recent Results Cancer Res. 2017;206:37–56.

Article  PubMed  Google Scholar 

Chen XM, Liu YY, Tao BY, Xue XM, Zhang XX, Wang LL, Zhong H, Zhang J, Yang SM, Jiang QQ. NT5E upregulation in head and neck squamous cell carcinoma: a novel biomarker on cancer-associated fibroblasts for predicting immunosuppressive tumor microenvironment. Front Immunol. 2022;13: 975847.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen YH, Lu HI, Lo CM, Li SH. CD73 promotes tumor progression in patients with esophageal squamous cell carcinoma. Cancers. 2021; 13(16).

Gao L, Zhang W, Zhong WQ, Liu ZJ, Li HM, Yu ZL, Zhao YF. Tumor associated macrophages induce epithelial to mesenchymal transition via the EGFR/ERK1/2 pathway in head and neck squamous cell carcinoma. Oncol Rep. 2018;40(5):2558–72.

CAS  PubMed  PubMed Central  Google Scholar 

Gao ZW, Liu C, Yang L, Chen HC, Yang LF, Zhang HZ, Dong K. CD73 severed as a potential prognostic marker and promote lung cancer cells migration via enhancing EMT progression. Front Genet. 2021;12: 728200.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Holz C, Niehr F, Boyko M, Hristozova T, Distel L, Budach V, Tinhofer I. Epithelial-mesenchymal-transition induced by EGFR activation interferes with cell migration and response to irradiation and cetuximab in head and neck cancer cells. Radiother Oncol. 2011;101(1):158–64.

Article  CAS  PubMed  Google Scholar 

Huang C, Chen L, Savage SR, Eguez RV, Dou Y, Li Y, da Veiga Leprevost F, Jaehnig EJ, Lei JT, Wen B, Schnaubelt M, Krug K, Song X, Cieslik M, Chang HY, Wyczalkowski MA, Li K, Colaprico A, Li QK, Clark DJ, Hu Y, Cao L, Pan J, Wang Y, Cho KC, Shi Z, Liao Y, Jiang W, Anurag M, Ji J, Yoo S, Zhou DC, Liang WW, Wendl M, Vats P, Carr SA, Mani DR, Zhang Z, Qian J, Chen XS, Pico AR, Wang P, Chinnaiyan AM, Ketchum KA, Kinsinger CR, Robles AI, An E, Hiltke T, Mesri M, Thiagarajan M, Weaver AM, Sikora AG, Lubinski J, Wierzbicka M, Wiznerowicz M, Satpathy S, Gillette MA, Miles G, Ellis MJ, Omenn GS, Rodriguez H, Boja ES, Dhanasekaran SM, Ding L, Nesvizhskii AI, El-Naggar AK, Chan DW, Zhang H, Zhang B, Clinical Proteomic Tumor Analysis C. Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma. Cancer Cell. 2021;39:361–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huynh NC, Huang TT, Nguyen CT, Lin FK. Comprehensive integrated single-cell whole transcriptome analysis revealed the p-EMT tumor cells-CAFs communication in oral squamous cell carcinoma. Int J Mol Sci. 2022; 23(12).

Ingruber J, Dudas J, Sprung S, Lungu B, Mungenast F. Interplay between partial EMT and cisplatin resistance as the drivers for recurrence in HNSCC. Biomedicines. 2022; 10(10).

Iser IC, Lenz G, Wink MR. EMT-like process in glioblastomas and reactive astrocytes. Neurochem Int. 2019;122:139–43.

Article  CAS  PubMed  Google Scholar 

Iser IC, Vedovatto S, Oliveira FD, Beckenkamp LR, Lenz G, Wink MR. The crossroads of adenosinergic pathway and epithelial-mesenchymal plasticity in cancer. Semin Cancer Biol. 2022;86(Pt 2):202–13.

Article  CAS  PubMed  Google Scholar 

Jensen DH, Dabelsteen E, Specht L, Fiehn AM, Therkildsen MH, Jonson L, Vikesaa J, Nielsen FC, von Buchwald C. Molecular profiling of tumour budding implicates TGFbeta-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma. J Pathol. 2015;236(4):505–16.

Article  CAS  PubMed  Google Scholar 

Keck MK, Zuo Z, Khattri A, Stricker TP, Brown CD, Imanguli M, Rieke D, Endhardt K, Fang P, Bragelmann J, DeBoer R, El-Dinali M, Aktolga S, Lei Z, Tan P, Rozen SG, Salgia R, Weichselbaum RR, Lingen MW, Story MD, Ang KK, Cohen EE, White KP, Vokes EE, Seiwert TY. Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes. Clin Cancer Res. 2015;21(4):870–81.

Article  CAS  PubMed  Google Scholar 

Kellner M, von Neubeck B, Czogalla B, Feederle R, Vick B, Jeremias I, Zeidler R. A novel anti-CD73 antibody that selectively inhibits membrane CD73 shows antitumor activity and induces tumor immune escape. Biomedicines. 2022; 10(4).

Kisoda S, Mouri Y, Kitamura N, Yamamoto T, Miyoshi K, Kudo Y. The role of partial-EMT in the progression of head and neck squamous cell carcinoma. J Oral Biosci. 2022;64(2):176–82.

Article  CAS  PubMed  Google Scholar 

Klinghammer K, Otto R, Raguse JD, Albers AE, Tinhofer I, Fichtner I, Leser U, Keilholz U, Hoffmann J. Basal subtype is predictive for response to cetuximab treatment in patient-derived xenografts of squamous cell head and neck cancer. Int J Cancer. 2017;141(6):1215–21.

Article  CAS  PubMed  Google Scholar 

Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell. 2017;168(4):670–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Le X, Negrao MV, Reuben A, Federico L, Diao L, McGrail D, Nilsson M, Robichaux J, Munoz IG, Patel S, Elamin Y, Fan YH, Lee WC, Parra E, Solis Soto LM, Chen R, Li J, Karpinets T, Khairullah R, Kadara H, Behrens C, Sepesi B, Wang R, Zhu M, Wang L, Vaporciyan A, Roth J, Swisher S, Haymaker C, Zhang J, Wang J, Wong KK, Byers LA, Bernatchez C, Zhang J, Wistuba II, Gibbons DL, Akbay EA, Heymach JV. Characterization of the immune landscape of EGFR-mutant NSCLC identifies CD73/adenosine pathway as a potential therapeutic target. J Thorac Oncol. 2021;16(4):583–600.

Article  CAS  PubMed  Google Scholar 

Lee H, Lin EC, Liu L, Smith JW. Gene expression profiling of tumor xenografts: In vivo analysis of organ-specific metastasis. Int J Cancer. 2003;107(4):528–34.

Article  CAS  PubMed  Google Scholar 

Leemans CR, Snijders PJF, Brakenhoff RH. The molecular landscape of head and neck cancer. Nat Rev Cancer. 2018;18(5):269–82.

Article  CAS  PubMed  Google Scholar 

Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, Tamayo P. the molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu C, Gao ZW, Wang X, Lin F, Zhang HZ, Dong K. CD73 promotes cervical cancer growth via EGFR/AKT1 pathway. Transl Cancer Res. 2022;11(5):1089–98.

Article  PubMed  PubMed Central  Google Scholar 

Lu T, Zhang Z, Zhang J, Pan X, Zhu X, Wang X, Li Z, Ruan M, Li H, Chen W, Yan M. CD73 in small extracellular vesicles derived from HNSCC defines tumour-associated immunosuppression mediated by macrophages in the microenvironment. J Extracell Vesicles. 2022;11(5): e12218.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lupia M, Angiolini F, Bertalot G, Freddi S, Sachsenmeier KF, Chisci E, Kutryb-Zajac B, Confalonieri S, Smolenski RT, Giovannoni R, Colombo N, Bianchi F, Cavallaro U. CD73 regulates stemness and epithelial-mesenchymal transition in ovarian cancer-initiating cells. Stem Cell Rep. 2018;10(4):1412–25.

Article  CAS  Google Scholar 

Ma XL, Hu B, Tang WG, Xie SH, Ren N, Guo L, Lu RQ. CD73 sustained cancer-stem-cell traits by promoting SOX9 expression and stability in hepatocellular carcinoma. J Hematol Oncol. 2020;13(1):11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma XL, Shen MN, Hu B, Wang BL, Yang WJ, Lv LH, Wang H, Zhou Y, Jin AL, Sun YF, Zhang CY, Qiu SJ, Pan BS, Zhou J, Fan J, Yang XR, Guo W. CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110beta and predicts poor prognosis. J Hematol Oncol. 2019;12(1):37.

Article  PubMed  PubMed Central  Google Scholar 

Mack B, Gires O. CD44s and CD44v6 expression in head and neck epithelia. PLoS ONE. 2008;3(10): e3360.

Article  PubMed  PubMed Central  Google Scholar 

Makitie AA, Almangush A, Rodrigo JP, Ferlito A, Leivo I. Hallmarks of cancer: Tumor budding as a sign of invasion and metastasis in head and neck cancer. Head Neck. 2019;41(10):3712–8.

Article  PubMed  Google Scholar 

Mandapathil M, Boduc M, Netzer C, Guldner C, Roessler M, Wallicek-Dworschak U, Jahns E, Stuck B. CD73 expression in lymph node metastases in patients with head and neck cancer. Acta Otolaryngol. 2018;138(2):180–4.

Article